Clinical Trials Logo

Head Neck Tumors clinical trials

View clinical trials related to Head Neck Tumors.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT04166006 Recruiting - Clinical trials for Neuroendocrine Tumors

A Phase II Study on Adjuvant Vaccination With Dendritic Cells Loaded With Autologous Tumor Homogenate in Resected Stage IV Rare Cancers.

RaC-Ad
Start date: December 12, 2019
Phase: Phase 2
Study type: Interventional

Single-arm, monocentric trial to assess safety and immunological efficacy of adjuvant vaccination with autologous dendritic cells loaded with autologous tumour homogenate after curative resection for stage IV rare cancers (In Head/Neck tumors (H&N), NEuroendocrine Tumors (NET) and Soft Tissue Sarcomas (STS).